Barely Significant
← all excerpts

Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive Review.

Vaccines (Basel) · 2025 · PMC12298472 · PMID 40733704

Europe PMCDOI
1
hedged sentence
0.0494
closest p · 1.0× alpha
0.0494
boldest claim

The sentences

showed a trendP = 0.0494actually significant
The T-VEC arm showed a trend towards better OS (23.3 vs. 18.9 months, unstratified hazard ratio (HR), 0.79; 95% confidence interval (CI), 0.62–1.00; P = 0.0494 [descriptive]) and a better DRR (19.0% vs. 1.4%, unadjusted odds ratio (OR), 16.6; 95% CI, 4.0–69.2; P < 0.0001) [ 73 ].

also in 33,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.